S 229 119th Congress Senate Health Administrative law and regulatory procedures Civil actions and liability Department of Health and Human Services Health care costs and insurance Marketing and advertising Prescription drugs

DTC Act of 2025

Introduced: January 23, 2025 Introduced by: Durbin, Richard J. Democratic · Illinois See on congress.gov

Everywhere this bill has been 2 steps

Introduced

In committee

Reported out

Passed House

Passed Senate

To President

Became law

Jan 23, 2025

Read twice and referred to the Committee on Finance. (text: CR S337-338; Sponsor introductory remarks on measure: CR S337)

Jan 23, 2025

Introduced in Senate

Plain-English summary Congressional Research Service

Drug-price Transparency for Consumers Act of 2025 or the DTC Act of 2025

This bill requires consumer advertisements for prescription drugs and biological products to include certain price information if the drug or biologic is (1) covered under Medicare or Medicaid, and (2) required to include a risk summary under current law.

Specifically, such advertisements must clearly and conspicuously disclose the wholesale price for a 30-day supply of the drug or biologic and may explain that a consumer may pay a different amount for the drug or biologic depending on the consumer's health insurance coverage.

The requirement does not apply to advertisements for drugs or biologics with a wholesale cost of less than $35 for a one-month supply.

Each violation of this requirement is subject to a civil penalty of not more than $100,000.

What's happening now January 23, 2025

Read twice and referred to the Committee on Finance. (text: CR S337-338; Sponsor introductory remarks on measure: CR S337)

Committees of jurisdiction 1